Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects

Clinica Chimica Acta

Volumn 355, Issue 1-2, 2005, Pages 165-172

  Helfenstein, Tatiana ^a   Fonseca, Francisco A H ^a   Relvas, Waldir G M ^a   Santos, Andreza O ^a   Dabela, Maria L ^a   Matheus, Simone C P ^a   D'Almeida, Vânia ^b   Tufik, Sérgio ^a   Souza, Fernanda G ^b   Rodrigues, Paula R ^a   Taglieri, Rosely ^a   Sousa, Éder F ^a   Izar, Maria C O ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Diabetes mellitus; Homocysteine; Methionine synthase; Methylenetetrahydrofolate reductase; Myocardial infarction; Polymorphisms

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; METHIONINE SYNTHASE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENETIC POLYMORPHISM; HEART INFARCTION; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; VITAMIN BLOOD LEVEL;

EID: 20144387917     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.12.002     Document Type: Article

References (37)

1. P. Goyette, P. Frosst, D.S. Rosenblatt, and R. Rozen Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency Am. J. Hum. Genet. 56 1995 1052 1059
2. D. Leclerc, E. Campeau, P. Goyette, C.E. Adjalla, B. Christensen, and M. Ross Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders Hum. Mol. Genet. 5 1996 1867 1874
3. J.J. Genest Jr., J.R. McNamara, D.N. Salem, P.W. Wilson, E.J. Schaefer, and M.R. Malinow Plasma homocyst(e)ine levels in men with premature coronary artery disease J. Am. Coll. Cardiol. 16 1990 1114 1119
4. J. Selhub, P.F. Jacques, A.G. Bostom, R.B. D'Agostino, P.W. Wilson, and A.J. Belanger Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis N. Engl. J. Med. 332 1995 286 291
5. I.J. Perry, H. Refsum, R.W. Morris, S.B. Ebrahim, P.M. Ueland, and A.G. Shaper Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men Lancet 346 1995 1395 1398
6. W.S. Aronow, and C. Ahn Association between plasma homocysteine and peripheral arterial disease in older persons Coron. Artery Dis. 9 1998 49 50
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
8. G. DeBacker, E. Ambrosioni, K. Borch-Johnsen, C. Brotons, R. Cifkova, and J. Dallongeville European Society of Cardiology Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts) Eur. J. Cardiovasc. Prev. Rehabil. 10 2003 S1 S10
9. G.N. Welch, and J. Loscalzo Mechanisms of disease: homocysteine and atherothrombosis N. Engl. J. Med. 338 1998 1042 1050
10. E.K. Hoogeveen, P.J. Kostense, C. Jakobs, J.M. Dekker, G. Nijpels, and R.J. Heine Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes. 5-year follow-up of the Hoorn Study Circulation 101 2000 1506 1511
11. D. Avramopoulos, T. Cox, J.P. Kraus, A. Chakravarti, and S.E. Antonarakis Linkage mapping of the cystathionine beta-synthase (CBS) gene on human chromosome 21 using a DNA polymorphism in the 3′ untranslated region Hum. Genet. 90 1993 566 568
12. B. Fowler Disorders of homocysteine metabolism J. Inherit. Metab. Dis. 20 1997 270 285
13. C.L. Chao, H.H. Tsai, C.M. Lee, S.M. Hsu, J.T. Kao, and K.L. Chien The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis Atherosclerosis 147 1999 379 386
14. X.L. Wang, N. Duarte, H. Cai, T. Adachi, A.S. Sim, and G. Cranney Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population Atherosclerosis 146 1999 133 140
15. M.E. Hyndman, P.J. Bridge, W. Warnica, G. Fick, and H.G. Parsons Effect of heterozygosity for the methionine synthase A2756G mutation on the risk for recurrent cardiovascular events Am. J. Cardiol. 86 2000 1144 1146
16. D.E. Zylberstein, C. Bengtsson, C. Björkelund, S. Landaas, V. Sundh, and D. Thelle Serum homocysteine in relation to mortality and morbidity from coronary heart disease: A 24-year follow-up of the population study of women in Gothenburg Circulation 109 2004 601 606
17. G. Buccianti, I. Baragetti, F. Bamonti, S. Furiani, V. Dorighet, and C. Patrosso Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease J. Nephrol. 17 2004 405 410
18. A. Passaro, F. Calzoni, S. Volpato, E.D. Nora, P.L. Pareschi, and P.F. Zamboni Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up J. Intern. Med. 254 2003 264 271
19. American Diabetes Association: consensus statement Diabetes Care 18 1995 1510 1537
20. World Health Organization The world health report 2002 2002 World Health Organization Geneva
21. R.L. Karvetti, and Knuts Jr. Validity of the 24-hour dietary recall J. Am. Diet. Assoc. 85 1985 1437
22. J.M. Karkeck Improving the use of dietary survey methodology J. Am. Diet. Assoc. 87 1987 869
23. P.P. Basiots Number of days of food intake records required to estimate individual and group nutrient intakes with defined confidence J. Nutr. 117 1987 1638
24. Departamento de Informática em Saúde-DIS-UNIFESP-EPM. Programa de apoio à Nutrição-Nutwin. [computer program]. Version 1.5. Sao Paulo, 2000.
25. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clin. Chem. 18 1972 499 502
26. C.M. Pfeiffer, D.L. Huff, and E.W. Gunter Rapid and accurate HPLC assay for plasma and total homocysteine and cysteine in a clinical laboratory setting Clin. Chem. 45 1999 290 292
27. E.N. da Cruz, V. D'Almeida, L.C. Cardien, C.A. Terzi, D.C. Diniz, and A.C.C. Carvalho Standardization of homocysteine determination by high pressure liquid chromatography and application on coronary artery disease patients J. Bras. Patol. 36 2000 166 173
28. P. Frosst, H.J. Blom, R. Milos, P. Goyette, C.A. Sheppard, and R.G. Mathews A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase Nat. Genet. 10 1995 111 113
29. D. Qujeq, T.S. Omran, and L. Hosini Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction Clin. Biochem. 34 2001 97 101
30. D.J. Vanderjagt, R.J. Patel, A.U. El-Nafaty, G.S. Melah, M.J. Crossey, and R.H. Glew High-density lipoprotein and homocysteine levels correlate inversely in preeclamptic women in northern Nigeria Acta Obstet. Gynecol. Scand. 83 2004 536 542
31. T.D. Stamos, and R.S. Rosenson Low high density lipoprotein levels are associated with an elevated blood viscosity Atherosclerosis 146 1999 161 165
32. R.S. Rosenson, and G.D. Lowe Effects of lipids and lipoproteins on thrombosis and rheology Atherosclerosis 140 1998 271 280
33. K.S. McCully Homocysteine and vascular disease Nat. Med. 2 1996 386 389
34. E. Falk, J. Zhou, and J. Moller Homocysteine and atherothrombosis Lipids 36 2001 S3 S11 (Suppl.)
35. G.T. Russo, A. Di Benedetto, C. Giorda, E. Alessi, G. Crisafulli, and R. Ientile Correlates of total homocysteine plasma concentration in type 2 diabetes Eur. J. Clin. Invest. 34 2004 197 204
36. M. Soinio, J. Marniemi, M. Laakso, L. Seppo, and T. Ronnemaa Elevated plasma homocysteine level is an independent predictor of coronary artery disease events in patients with type 2 diabetes mellitus Ann. Intern. Med. 140 2004 94 100
37. J.F. Toole, M.R. Malinow, L.E. Chambless, J.D. Spence, L.C. Pettigrew, and V.J. Howard Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial JAMA 291 2004 565 575